Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease (IBD) including ulcerative colitis, today ...
Readouts from Novo Nordisk and Viking Therapeutics at AASLD 2024 strengthen the argument for GLP-1 therapies as an emerging ...
Big-bellied beer swillers chomping down on crisps and lumps of deep-fried chicken in a smoky pub while throwing darts and roaring at a big screen showing a football match. Meanwhile, at the gastro ...